Results showed that bufalin treatment markedly decreased the protein levels of Ki-67, and increased the expression of Claudin-1 in tumor tissues (Fig. 7e), suggesting that bufalin inhibited tumor proliferation and impede EMT signaling pathway in HCC xenografts. The gene discussed is CLDN1; the disease is hepatocellular carcinoma.